Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Using Doxepin for Urticaria [Phase 3]

View source ↗

Summary

Phase 3 trial investigating doxepin for urticaria is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxepin (Doxepin)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Urticaria | Phase 3 | Status: UNKNOWN